Skip to content
  • CAT
  • ESP
  • ENG
  • About us
  • Contact
El·lipse
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • Research
  • Public engagement
  • Scientific life
  • Community
  • About us
  • Contact
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • CAT
  • ESP
  • ENG

Cell division

Dyed cells
24.03.2025

The formation of the mitotic spindle depends on just two molecules

24.05.2024

Discovery of a key gene in certain types of lung cancer

15.05.2023

Collecting proteins

09.12.2022

A cell division enzyme as a possible therapeutic target against cancer

29.11.2021

A strategic agreement to accelerate the development of new drugs

25.11.2021

Discovered the mechanism for the separation of cells during cell division

25.05.2020

Formation of epithelial-like structures in single-celled organisms

PARP inhibitors are considered a potential treatment for cancer. | Picture by National Cancer Institute from Unsplash.
24.02.2020

Designing PARP-specific inhibitors would enhance their effectiveness against cancer

Women have two copies of chromosome X, while men have one X and one Y. This little Y chromosome holds the key to why men have higher risk of cancer. Photo by Kate Whitley CC-BY.
17.01.2020

Six Y chromosome genes could explain men’s increased risk of cancer

Organising an international conference has been a rewarding challenge for these PhD students.
12.04.2019

A PhD’s guide on how to organize a conference

Elvan Böke set up and has been directing the Oocyte Biology and Cellular Dormancy group since 2017.
07.06.2018

“You cannot have an old baby”

Oxidative Stress and Cell Cycle research group (DCEXS-UPF), co-leaded by Elena Hidalgo and José Ayté.
16.01.2017

“Oxidative stress and cell cycle control: two converging pathways”

El·lipse is published by the PRBB Communications and Corporate Relations Area.

Dr Aiguader, 88, 08003 Barcelona, Spain

For any suggestions or collaborations please contact us at ellipse@prbb.org

  • Read past print editions
  • About El·lipse
  • About the PRBB
  • Legal disclaimer
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
© 2026 El·lipse, PRBB
  • Home
  • News
  • Our picks
This website uses cookies that provide us with personal information, such as data associated with your browsing. If you click on I AGREE, both we and our Partners can install cookies or access non-sensitive information on your device in order to facilitate the reproduction of content, provide features on social networks, create profiles and compile statistics on traffic and usability in our website. You can get MORE INFORMATION by accessing our COOKIES POLICY. I agree More information
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
Subscribe to our mailing list
Want to be the first to know everything that goes on at the biggest biomedical research hub in Southern Europe? Subscribe to the el·lipse newsletter!

We will send you an email with the latest news.

See you soon!

*Required field

Field is not valid
You have to authorize data treatment

At any time, you can exercise the rights of access, rectification, opposition, portability, limitation to treatment and deletion of the data subject to treatment by clicking on the links "Update data" and "Unsubscribe", sending a letter indicating the right exercised to the postal address indicated at the bottom or to the following email address ellipse@prbb.org